GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (BOM:543434) » Definitions » ROE % Adjusted to Book Value

Supriya Lifescience (BOM:543434) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience ROE % Adjusted to Book Value?

Supriya Lifescience's ROE % for the quarter that ended in Dec. 2024 was 20.66%. Supriya Lifescience's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Supriya Lifescience's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.


Supriya Lifescience ROE % Adjusted to Book Value Historical Data

The historical data trend for Supriya Lifescience's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience ROE % Adjusted to Book Value Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - 5.33 6.24 4.81

Supriya Lifescience Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.54 - 4.08 -

Competitive Comparison of Supriya Lifescience's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Supriya Lifescience's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supriya Lifescience's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's ROE % Adjusted to Book Value falls into.


;
;

Supriya Lifescience ROE % Adjusted to Book Value Calculation

Supriya Lifescience's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=15.73% / 3.27
=4.81%

Supriya Lifescience's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=20.66% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Supriya Lifescience Business Description

Traded in Other Exchanges
Address
Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience Headlines

No Headlines